feed,title,long_url,short_url
SeekingAlpha,On the hour,https://seekingalpha.com/news/3722864,
SeekingAlpha,Cytokinetics opens enrollment for late-stage reldesemtiv ALS study,https://seekingalpha.com/news/3722861,
SeekingAlpha,Immunovant nabs $200M strategic investment from Roivant Sciences,https://seekingalpha.com/news/3722860,
SeekingAlpha,Bloomin' Brands rallies after Deutsche Bank calls out appetizing risk-reward profile,https://seekingalpha.com/news/3722859,
SeekingAlpha,Cytokinetics opens enrollment for late-stage reldesemtiv ALS study,https://seekingalpha.com/news/3722858,
